SCHEMBL24409482

SCHEMBL24409482

CC(C)(C)O/N=C(\c1ccccc1)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.43
▸ TDP1 Q9NUW8 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ ELANE P08246 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TNF P01375 1/20 0.35
▸ KLF5 Q13887 1/20 0.35
▸ NOD1 Q9Y239 1/20 0.35
▸ ALOX15 P16050 1/20 0.33
▸ ATM Q13315 1/20 0.32
▸ ESRRG P62508 1/20 0.32
▸ SRC P12931 1/20 0.32
▸ CES1 P23141 1/20 0.32
▸ RXRA P19793 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25890327 0.82 GAA (0.44) GAATDP1ALDH1A1TSHRHSD17B10
SCHEMBL28735868 0.79 ALDH1A1 (0.42) GAATDP1ALDH1A1TSHRHSD17B10
SCHEMBL28541958 0.74 GAA (0.64) GAATDP1ALDH1A1TSHRHSD17B10
SCHEMBL22512523 0.74 GAA (0.48) GAATDP1ALDH1A1TSHRHSD17B10
SCHEMBL20744865 0.73 HPGD (0.41) GAATDP1ALDH1A1TSHRHSD17B10
SCHEMBL20744868 0.73 HPGD (0.41) GAATDP1ALDH1A1TSHRHSD17B10
SCHEMBL25575375 0.72 GAA (0.47) GAATDP1ALDH1A1TSHRHSD17B10
Fluoride SCHEMBL27890616 0.72 GAA (0.62) GAATDP1ALDH1A1TSHRHSD17B10
SCHEMBL6547975 0.72 ATM (0.41) GAATDP1ALDH1A1TSHRHSD17B10
SCHEMBL14347349 0.68 TSHR (0.47) GAATDP1ALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220143012-A1 Macromolecule-Supported TLR Agonists BOLT BIOTHERAPEUTICS, INC. (US) 2022-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220143012-A1 Macromolecule-Supported TLR Agonists TLR8, TLR7, TLR9 GAA 1794/4885TDP1 2377/4885ALDH1A1 2748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback